about
MicroRNA-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting oncogene BMI-1Circulating microRNA testing for the early diagnosis and follow-up of colorectal cancer patientsSynthesis of new class dipeptide analogues with improved permeability and antithrombotic activityToward the development of chemoprevention agents. Part 1: Design, synthesis, and anti-inflammatory activities of a new class of 2,5-disubstituted-dioxacycloalkanesToward the development of chemoprevention agents. Part II: Chemo-enzymatic synthesis and anti-inflammatory activities of a new class of 5-amino-2-substitutedphenyl-1,3-dioxacycloalkanesMulti-level gene expression profiles affected by thymidylate synthase and 5-fluorouracil in colon cancer.Reduction of Orc6 expression sensitizes human colon cancer cells to 5-fluorouracil and cisplatinSystematic evaluation of three microRNA profiling platforms: microarray, beads array, and quantitative real-time PCR array.Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cells.Prognostic significance of miR-181b and miR-21 in gastric cancer patients treated with S-1/Oxaliplatin or Doxifluridine/Oxaliplatin.miR-129 as a novel therapeutic target and biomarker in gastrointestinal cancerPrognostic significance of miR-205 in endometrial cancer.Down-regulated miR-625 suppresses invasion and metastasis of gastric cancer by targeting ILK.Conversion of stationary to invasive tumor initiating cells (TICs): role of hypoxia in membrane type 1-matrix metalloproteinase (MT1-MMP) traffickingIdentification of a stem-like cell population by exposing metastatic breast cancer cell lines to repetitive cycles of hypoxia and reoxygenationHighly stable and sensitive fluorescent probes (LysoProbes) for lysosomal labeling and tracking.Lysosomal targeting with stable and sensitive fluorescent probes (Superior LysoProbes): applications for lysosome labeling and tracking during apoptosisImplications of microRNAs in colorectal cancer development, diagnosis, prognosis, and therapeutics.Genetic variant rs16430 6bp > 0bp at the microRNA-binding site in TYMS and risk of sporadic breast cancer risk in non-Hispanic white women aged ≤ 55 yearsPrognostic significance of miR-215 in colon cancer.Inhibition of autophagy and tumor growth in colon cancer by miR-502.Simultaneous gene expression analysis of steady-state and actively translated mRNA populations from osteosarcoma MG-63 cells in response to IL-1alpha via an open expression analysis platform.Systematic analysis of microRNA fingerprints in thrombocythemic platelets using integrated platforms.Computed tomography-guided permanent brachytherapy for locoregional recurrent gastric cancer.Regulation of p53 expression by thymidylate synthaseLarge isoform of MRJ (DNAJB6) reduces malignant activity of breast cancer.Mutant p53 gain-of-function induces epithelial-mesenchymal transition through modulation of the miR-130b-ZEB1 axis.Growth of cancer cell lines under stem cell-like conditions has the potential to unveil therapeutic targets.Spheroid-forming subpopulation of breast cancer cells demonstrates vasculogenic mimicry via hsa-miR-299-5p regulated de novo expression of osteopontinmiRNAs as biomarkers in colorectal cancer diagnosis and prognosis.Impact of miRNAs in gastrointestinal cancer diagnosis and prognosis.MicroRNA: a third dimension in autophagy.Beyond Thymidylate Synthase and Dihydrofolate Reductase: Impact of Non-coding microRNAs in Anticancer Chemoresistance.Identification of KLF17 as a novel epithelial to mesenchymal transition inducer via direct activation of TWIST1 in endometrioid endometrial cancer.Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer.Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples.Gene expression profiles classify human osteosarcoma xenografts according to sensitivity to doxorubicin, cisplatin, and ifosfamide.miR-15a inhibits cell proliferation and epithelial to mesenchymal transition in pancreatic ductal adenocarcinoma by down-regulating Bmi-1 expression.Clinical significance of long intergenic noncoding RNA-p21 in colorectal cancer.Overexpressed miR-301a promotes cell proliferation and invasion by targeting RUNX3 in gastric cancer.
P50
Q21245764-F882CAE8-1F07-4C1B-8EB9-B1A49EA1F60EQ26996424-E5C05754-B7E8-496D-A31A-3BB498C46DD4Q28196591-AB2F993A-1C6A-478E-A8B0-94E891EDA42CQ28211083-ED417751-7C94-459D-9EEE-A248C2737341Q28217958-CAC126A2-01B7-4480-A066-FDDD53980EE3Q33238496-415F6068-3691-4DA0-8A8C-6C3D4C34A996Q33396223-A1D505A9-A7D7-4434-AE4A-0043E25ED062Q33828375-16835E00-4270-4409-9251-91698FD9E316Q33895297-788FC895-DB23-4C97-B5D5-E6428278E62CQ34005444-7ADF7511-8F5F-4E01-8BCE-E910A17DFD91Q34109826-61304DA7-A537-4813-9ECD-898370BB1117Q34238901-67052948-100D-4497-98F7-6E5C7F4FF528Q34279682-C669F102-9B8D-4867-9DD1-DFAD6A28E5BCQ34297111-08CBC1BE-9DF3-4F33-85D7-CF169802D1F6Q34613520-708FDC8A-45F0-4654-9384-9653851D4DF8Q35123611-16A3DEDE-BCA9-4CC6-9E57-F91F8911D9B6Q35165771-E04D620E-498B-4735-8424-13CAA5EFA3EFQ35565247-DD73DFA4-621D-4557-B263-B02FF50B20F1Q35731144-BB8B399D-D950-4819-A374-0E00343C3EACQ36077545-BA128BFC-5948-497F-BDA1-931AC17933F4Q36173829-06B4B151-66CA-4C0F-A5EB-97E8AAAFA102Q36247680-B9F8E5E1-4F6B-42ED-9809-A9EF9E6F3BDCQ36352553-FACD6432-71C7-4497-8DF6-97538ACE3CA0Q36359981-ABE04A48-9697-403F-B89E-7F6CB9D51C41Q36451021-03DE0398-277A-497A-BCE1-B141BE055B2EQ36678643-A7A76C14-BF70-4A48-9880-7EDECD08CF11Q36993572-70C22B28-E266-4F37-B6AF-ED0BD8369BA9Q37179767-8F6CEF33-CC73-4C9F-B275-18E53AA76D17Q37311025-910E040A-D480-4ADA-8D32-53B8990D2DE3Q37764707-DE17B850-C9F4-4044-A532-404DCA189B62Q37799873-04A21758-666E-4A85-9994-A4E1B7872813Q38068799-557BD017-37E9-4B0B-B467-317765B5EFB3Q38200600-C96181B1-4851-4B13-B2B5-7BF73817FB40Q38311270-484D2FE8-CAF1-4E04-8049-5B9637ADA1E8Q38314320-18B7EE50-6BD3-4458-AEEE-73BE5C8DE9F9Q38430803-6CE76449-E552-4978-9C09-26FBFB807EECQ38508335-244C6F73-945F-4050-8E02-21A3966B29ADQ39061411-625DE679-07AB-4210-B72B-76F3BFB4B06DQ39099143-E5C2493C-798D-47BD-91CD-067BFF021EC2Q39207080-8BBD9A48-4DF2-4BB9-9659-EA4F9BAC2E61
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Jingfang Ju
@ast
Jingfang Ju
@en
Jingfang Ju
@es
Jingfang Ju
@fr
Jingfang Ju
@nl
Jingfang Ju
@sl
type
label
Jingfang Ju
@ast
Jingfang Ju
@en
Jingfang Ju
@es
Jingfang Ju
@fr
Jingfang Ju
@nl
Jingfang Ju
@sl
prefLabel
Jingfang Ju
@ast
Jingfang Ju
@en
Jingfang Ju
@es
Jingfang Ju
@fr
Jingfang Ju
@nl
Jingfang Ju
@sl
P106
P1153
7202751154
P21
P31
P496
0000-0002-4821-7458